A RANDOMIZED PLACEBO-CONTROLLED TRIAL OF ATORVASTATIN IN HIV-POSITIVE PATIENTS NOT ON ANTIRETROVIRAL MEDICATIONS WITH THE SPECIFIC AIMS OF STUDYING THE EFFECTS OF ATORVASTATIN ON HIV VIRAL LOAD AND IMMUNE ACTIVATION MARKERS: